−0.09CAD
−3.92 MCAD
32.30 M
About THIOGENESIS THERAPEUTICS CORP
Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TTI is 0.75 CAD — it has increased by 1.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange THIOGENESIS THERAPEUTICS CORP stocks are traded under the ticker TTI.
TTI stock is 1.33% volatile and has beta coefficient of −0.03. Check out the list of the most volatile stocks — is THIOGENESIS THERAPEUTICS CORP there?
Yes, you can track THIOGENESIS THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
TTI stock has fallen by 6.25% compared to the previous week, the month change is a 9.64% fall, over the last year THIOGENESIS THERAPEUTICS CORP has showed a 7.14% increase.
TTI net income for the last quarter is −1.05 M CAD, while the quarter before that showed −870.39 K CAD of net income which accounts for −21.16% change. Track more THIOGENESIS THERAPEUTICS CORP financial stats to get the full picture.
Today THIOGENESIS THERAPEUTICS CORP has the market capitalization of 30.76 M, it has increased by 4.17% over the last week.
No, TTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THIOGENESIS THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THIOGENESIS THERAPEUTICS CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THIOGENESIS THERAPEUTICS CORP stock shows the buy signal. See more of THIOGENESIS THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.